Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Villajoyosa

13 clinical trials in Villajoyosa, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Villajoyosa at a glance
13
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

13 trials in Villajoyosa

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Psoriasis

Not yet recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Janssen - Cilag International
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Dermatitis atopic

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Dermatitis atopic

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

HIV infection

Not recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Fundacion Seimc Gesida

Psoriasis

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Brodalumab
  • Sponsor:LEO PHARMA A/S

Colitis ulcerative

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Villajoyosa

What the registry says about research in the country

01 Dermatology Research

Innovative studies focusing on plaque psoriasis and atopic dermatitis treatments, evaluating new therapeutic approaches for moderate to severe skin conditions.

  • Moderate to Severe Plaque Psoriasis
  • Atopic Dermatitis Management
  • Topical Treatment Evaluation

Research aims to provide enhanced treatment options for patients with resistant skin conditions.

02 Infectious Disease Studies

Groundbreaking research in HIV treatment, focusing on long-acting therapies and maintenance treatments for various patient populations.

  • HIV-1 Management
  • Viral Suppression Strategies
  • Age-Specific Treatment Approaches

Studies evaluate innovative therapeutic combinations for improved patient outcomes.

03 Rheumatology Initiatives

Comprehensive studies examining treatments for rheumatoid arthritis and axial spondyloarthritis, comparing different therapeutic approaches.

  • Rheumatoid Arthritis Treatment
  • Axial Spondyloarthritis Management
  • Autoimmune Disease Therapy

Research focuses on comparing treatment efficacy and safety profiles.

04 Autoimmune Conditions

Advanced research into systemic lupus erythematosus and ulcerative colitis, evaluating novel therapeutic approaches.

  • Early SLE Treatment
  • Ulcerative Colitis Management
  • Inflammatory Disease Control

Studies aim to improve disease management and patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.